441
Open house drug discount agreements for the active ingredient umeclidinium bromide, ATC R03BB07
Posting Date :
20-May-2025
Deadline :
30-Apr-2027
Notice Type :
Tenders
Location :
Germany
Reference No. :
1963216250520 - 0
|
442
Open house drug discount agreements for the active ingredient Dolutegravir, ATC J05AJ03
Posting Date :
20-May-2025
Deadline :
30-Apr-2027
Notice Type :
Tenders
Location :
Germany
Reference No. :
1963416250520 - 0
|
443
Open house drug discount agreements for the active ingredient Darifenacin, ATC G04BD10
Posting Date :
20-May-2025
Deadline :
30-Apr-2027
Notice Type :
Tenders
Location :
Germany
Reference No. :
1963516250520 - 0
|
444
Open house drug discount agreements for the active ingredient denosumab
Posting Date :
20-May-2025
Deadline :
30-Apr-2027
Notice Type :
Tenders
Location :
Germany
Reference No. :
1963616250520 - 0
|
445
Open house drug discount agreements for the active ingredient atovaquone, ATC P01AX06
Posting Date :
20-May-2025
Deadline :
30-Apr-2027
Notice Type :
Tenders
Location :
Germany
Reference No. :
1963716250520 - 0
|
446
Open house drug discount agreements for the active ingredient Bimekizumab, ATC L04AC21
Posting Date :
20-May-2025
Deadline :
30-Apr-2027
Notice Type :
Tenders
Location :
Germany
Reference No. :
1963816250520 - 0
|
447
Open house drug discount agreements for the active ingredient clindamycin and benzoyl peroxide, AT
Posting Date :
20-May-2025
Deadline :
30-Apr-2027
Notice Type :
Tenders
Location :
Germany
Reference No. :
1963916250520 - 0
|
448
Open house drug discount agreements for the active ingredient acitretin, ATC D05BB02
Posting Date :
20-May-2025
Deadline :
30-Apr-2027
Notice Type :
Tenders
Location :
Germany
Reference No. :
1964016250520 - 0
|
449
Pharmaceutical products
Posting Date :
21-May-2025
Deadline :
30-Apr-2027
Notice Type :
Tenders
Location :
Germany
Reference No. :
9137216250521 - 0
|
450
Open house drug discount agreements for the active ingredient Axitinib, ATC L01EK01
Posting Date :
21-May-2025
Deadline :
30-Apr-2027
Notice Type :
Tenders
Location :
Germany
Reference No. :
9140216250521 - 0
|
451
Open house drug discount agreements for the active ingredient darifenacin
Posting Date :
21-May-2025
Deadline :
30-Apr-2027
Notice Type :
Tenders
Location :
Germany
Reference No. :
9140416250521 - 0
|
452
Pharmaceutical products
Posting Date :
21-May-2025
Deadline :
30-Apr-2027
Notice Type :
Tenders
Location :
Germany
Reference No. :
9141116250521 - 0
|
453
Pharmaceutical products
Posting Date :
21-May-2025
Deadline :
30-Apr-2027
Notice Type :
Tenders
Location :
Germany
Reference No. :
9142116250521 - 0
|
454
Open house drug discount agreements for the active ingredient denosumab, trade name Xgeva
Posting Date :
21-May-2025
Deadline :
30-Apr-2027
Notice Type :
Tenders
Location :
Germany
Reference No. :
9142416250521 - 0
|
455
Pharmaceutical products
Posting Date :
21-May-2025
Deadline :
30-Apr-2027
Notice Type :
Tenders
Location :
Germany
Reference No. :
9142716250521 - 0
|
456
Pharmaceutical products
Posting Date :
21-May-2025
Deadline :
30-Apr-2027
Notice Type :
Tenders
Location :
Germany
Reference No. :
9143216250521 - 0
|
457
Pharmaceutical products
Posting Date :
21-May-2025
Deadline :
30-Apr-2027
Notice Type :
Tenders
Location :
Germany
Reference No. :
9144216250521 - 0
|
458
Pharmaceutical products
Posting Date :
21-May-2025
Deadline :
30-Apr-2027
Notice Type :
Tenders
Location :
Germany
Reference No. :
9145616250521 - 0
|
459
Open house drug discount agreements for the active ingredient umeclidinium bromide, ATC R03BB07
Posting Date :
21-May-2025
Deadline :
30-Apr-2027
Notice Type :
Tenders
Location :
Germany
Reference No. :
9149316250521 - 0
|
460
active ingredient distigmine, ATC N07AA03
Posting Date :
21-May-2025
Deadline :
30-Apr-2027
Notice Type :
Tenders
Location :
Germany
Reference No. :
9153416250521 - 0
|